Exact Mass: 532.2573

Roridin A

C29H40O9 (532.2672)

CONFIDENCE isolated standard D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

calactin

C29H40O9 (532.2672)

Calotropin

C29H40O9 (532.2672)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

PA(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H41O10P (532.2437)

PA(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Leukotriene B4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0)

C25H41O10P (532.2437)

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0), in particular, consists of one chain of one Leukotriene B4 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H41O10P (532.2437)

PA(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0)

C25H41O10P (532.2437)

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0), in particular, consists of one chain of one 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0)

C25H41O10P (532.2437)

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0), in particular, consists of one chain of one 5,6-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

8-O-Tigloylingol

C29H40O9 (532.2672)

Miotoxin D

C29H40O9 (532.2672)

Trichoverrin A

C29H40O9 (532.2672)

Zizyvoside I

C25H40O12 (532.252)

berkelic acid

C29H40O9 (532.2672)

Trichoverrin B

C29H40O9 (532.2672)

3-O-(2,6-Dideoxy-beta-D-xylo-hexopyranoside)-3,5,14-Trihydroxy-19-oxocarda-6,20(22)-dienolide

C29H40O9 (532.2672)

bistratamide F

C25H36N6O5S (532.2468)

A homodetic cyclic peptide that consists of L-threonine and L-valine and L-serine as the amino acid residues cyclised via amide bonds. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line

calcicolin A|rel-10betaH-trans-12-(2-methylbut-2(E)-enoyl)-1beta-isobutanoyl-6alpha,13-dihydroxyclerodan-4(20),8(18)-diene-7,15-dione 15,16-oxide

C29H40O9 (532.2672)

3,12-O-diacetyl-7-O-tigloylingol

C29H40O9 (532.2672)

kadnanolactone I

C29H40O9 (532.2672)

(9R)-2beta,9-dihydroxymegastigma-4,7-dien-3-one 9-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside

C25H40O12 (532.252)

Calactin|Calotropin

C29H40O9 (532.2672)

8-hydroxyroridin E

C29H40O9 (532.2672)

pre-schisanartanin C

C29H40O9 (532.2672)

elaeodendroside U

C29H40O9 (532.2672)

A cardenolide glycoside that is carda-4,20(22)-dienolide substituted by hydroxy groups at positions 2 and 14, an oxo group at position 12 and a (4-deoxy-3-O-methyl-alpha-L-erythro-pentopyranosyl)oxy moiety at position 3 (the 2alpha,3beta stereoisomer). Isolated from from wood of Elaeodendron tangenala, it exhibits antiproliferative activity against A2780 human ovarian cancer cells. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

chabamide H

C31H36N2O6 (532.2573)

C29H40O9

C29H40O9 (532.2672)

(6S,7R,Ra)-3-phenylacrylic acid 2,3,10,11,12-pentamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c]cycloocten-1-yl ester|neglschisandrin A

C32H36O7 (532.2461)

Isomorellinol

C32H36O7 (532.2461)

elaeodendroside S

C29H40O9 (532.2672)

Ajugalactone

C29H40O9 (532.2672)

gofruside

C29H40O9 (532.2672)

Humistratin

C29H40O9 (532.2672)

chabamide I

C31H36N2O6 (532.2573)

3-didehydroafroside

C29H40O9 (532.2672)

(6R,9R)-3-oxo-alpha-ionol-9-O-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside

C25H40O12 (532.252)

C25H40O12

C25H40O12 (532.252)

aspergillide C|aspergillipeptide C

C26H36N4O8 (532.2533)

balgacyclamide A

C25H36N6O5S (532.2468)

klymollin K

C26H41ClO9 (532.2439)

C36H36O4

C36H36O4 (532.2613)

1-[2-(Dimethylamino)-1-oxo-3-phenylpropyl]-2,3,3alpha,13alpha,14,15,16,18alpha-octahydro-8-methoxy-5,9-metheno-9H-dipyrrolo[3,2-b:1,2-e][1,5,8]oxadiazacyclopentadecine-13,18(1H,12H)-dione

C30H36N4O5 (532.2686)

16-Dehydro-strophanthidin-beta-D-digitoxosid

C29H40O9 (532.2672)

(20xi)-12beta-acetoxy-3beta,20-dihydroxy-7,11,15-trioxo-25,26,27-trisnorlanost-8-en-24-oic acid|20-hydroxylucidenic acid E2

C29H40O9 (532.2672)

2,7-Dihydroxy-2,8-dimethyl-4-vinyl-11-(2,8-dimethyl-7-hydroxy-9,10-dihydrophenanthrene-3-yl)-1,4-ethano-1,2,3,4,9,10-hexahydrophenanthrene-3-one

C36H36O4 (532.2613)

Thr Arg Gln Glu

C20H36N8O9 (532.2605)

Ala Ser Asn Asp Leu

C21H36N6O10 (532.2493)

C29H40O9_(1R,3aS,3bR,6aR,7aS,9R,11R,11aS,12aR,13aR,15aR)-3a,11,11a-Trihydroxy-9,15a-dimethyl-1-(5-oxo-2,5-dihydro-3-furanyl)icosahydro-7aH,13aH-cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxine-13a-carbaldehyde

C29H40O9 (532.2672)

Ala Ala Trp Trp

C28H32N6O5 (532.2434)

Ala Glu Lys Trp

C25H36N6O7 (532.2645)

Ala Glu Trp Lys

C25H36N6O7 (532.2645)

Ala Lys Glu Trp

C25H36N6O7 (532.2645)

Ala Lys Trp Glu

C25H36N6O7 (532.2645)

Ala Trp Ala Trp

C28H32N6O5 (532.2434)

Ala Trp Glu Lys

C25H36N6O7 (532.2645)

Ala Trp Lys Glu

C25H36N6O7 (532.2645)

Ala Trp Trp Ala

C28H32N6O5 (532.2434)

Cys Lys Pro Trp

C25H36N6O5S (532.2468)

Cys Lys Trp Pro

C25H36N6O5S (532.2468)

Cys Pro Lys Trp

C25H36N6O5S (532.2468)

Cys Pro Trp Lys

C25H36N6O5S (532.2468)

Cys Trp Lys Pro

C25H36N6O5S (532.2468)

Cys Trp Pro Lys

C25H36N6O5S (532.2468)

Asp Asp Lys Arg

C20H36N8O9 (532.2605)

Asp Asp Arg Lys

C20H36N8O9 (532.2605)

Asp Lys Asp Arg

C20H36N8O9 (532.2605)

Asp Lys Arg Asp

C20H36N8O9 (532.2605)

Asp Arg Asp Lys

C20H36N8O9 (532.2605)

Asp Arg Lys Asp

C20H36N8O9 (532.2605)

Asp Arg Arg Ser

C19H36N10O8 (532.2717)

Asp Arg Ser Arg

C19H36N10O8 (532.2717)

Asp Ser Arg Arg

C19H36N10O8 (532.2717)

Glu Ala Lys Trp

C25H36N6O7 (532.2645)

Glu Ala Trp Lys

C25H36N6O7 (532.2645)

Glu Glu Lys Gln

C21H36N6O10 (532.2493)

Glu Glu Gln Lys

C21H36N6O10 (532.2493)

Glu Lys Ala Trp

C25H36N6O7 (532.2645)

Glu Lys Glu Gln

C21H36N6O10 (532.2493)

Glu Lys Gln Glu

C21H36N6O10 (532.2493)

Glu Lys Trp Ala

C25H36N6O7 (532.2645)

Glu Gln Glu Lys

C21H36N6O10 (532.2493)

Glu Gln Lys Glu

C21H36N6O10 (532.2493)

Glu Gln Arg Thr

C20H36N8O9 (532.2605)

Glu Gln Thr Arg

C20H36N8O9 (532.2605)

Glu Arg Gln Thr

C20H36N8O9 (532.2605)

Glu Arg Thr Gln

C20H36N8O9 (532.2605)

Glu Thr Gln Arg

C20H36N8O9 (532.2605)

Glu Thr Arg Gln

C20H36N8O9 (532.2605)

Glu Trp Ala Lys

C25H36N6O7 (532.2645)

Glu Trp Lys Ala

C25H36N6O7 (532.2645)

Phe His Met Val

C25H36N6O5S (532.2468)

Phe His Val Met

C25H36N6O5S (532.2468)

Phe Met His Val

C25H36N6O5S (532.2468)

Phe Met Val His

C25H36N6O5S (532.2468)

Phe Val His Met

C25H36N6O5S (532.2468)

Phe Val Met His

C25H36N6O5S (532.2468)

Gly Asp Trp Arg

C23H32N8O7 (532.2394)

Gly Arg Asp Trp

C23H32N8O7 (532.2394)

Gly Trp Asp Arg

C23H32N8O7 (532.2394)

Gly Trp Arg Asp

C23H32N8O7 (532.2394)

His Phe Met Val

C25H36N6O5S (532.2468)

His Phe Val Met

C25H36N6O5S (532.2468)

His Ile Thr Tyr

C25H36N6O7 (532.2645)

His Ile Tyr Thr

C25H36N6O7 (532.2645)

His Leu Thr Tyr

C25H36N6O7 (532.2645)

His Leu Tyr Thr

C25H36N6O7 (532.2645)

His Met Phe Val

C25H36N6O5S (532.2468)

His Met Val Phe

C25H36N6O5S (532.2468)

His Thr Ile Tyr

C25H36N6O7 (532.2645)

His Thr Leu Tyr

C25H36N6O7 (532.2645)

His Thr Tyr Ile

C25H36N6O7 (532.2645)

His Thr Tyr Leu

C25H36N6O7 (532.2645)

His Val Phe Met

C25H36N6O5S (532.2468)

His Val Met Phe

C25H36N6O5S (532.2468)

His Tyr Ile Thr

C25H36N6O7 (532.2645)

His Tyr Leu Thr

C25H36N6O7 (532.2645)

His Tyr Thr Ile

C25H36N6O7 (532.2645)

His Tyr Thr Leu

C25H36N6O7 (532.2645)

Ile His Thr Tyr

C25H36N6O7 (532.2645)

Ile His Tyr Thr

C25H36N6O7 (532.2645)

Ile Asn Thr Trp

C25H36N6O7 (532.2645)

Ile Asn Trp Thr

C25H36N6O7 (532.2645)

Ile Gln Ser Trp

C25H36N6O7 (532.2645)

Ile Gln Trp Ser

C25H36N6O7 (532.2645)

Ile Ser Gln Trp

C25H36N6O7 (532.2645)

Ile Ser Trp Gln

C25H36N6O7 (532.2645)

Ile Thr His Tyr

C25H36N6O7 (532.2645)

Ile Thr Asn Trp

C25H36N6O7 (532.2645)

Ile Thr Trp Asn

C25H36N6O7 (532.2645)

Ile Thr Tyr His

C25H36N6O7 (532.2645)

Ile Trp Asn Thr

C25H36N6O7 (532.2645)

Ile Trp Gln Ser

C25H36N6O7 (532.2645)

Ile Trp Ser Gln

C25H36N6O7 (532.2645)

Ile Trp Thr Asn

C25H36N6O7 (532.2645)

Ile Tyr His Thr

C25H36N6O7 (532.2645)

Ile Tyr Thr His

C25H36N6O7 (532.2645)

Lys Ala Glu Trp

C25H36N6O7 (532.2645)

Lys Ala Trp Glu

C25H36N6O7 (532.2645)

Lys Cys Pro Trp

C25H36N6O5S (532.2468)

Lys Cys Trp Pro

C25H36N6O5S (532.2468)

Lys Asp Asp Arg

C20H36N8O9 (532.2605)

Lys Asp Arg Asp

C20H36N8O9 (532.2605)

Lys Glu Ala Trp

C25H36N6O7 (532.2645)

Lys Glu Glu Gln

C21H36N6O10 (532.2493)

Lys Glu Gln Glu

C21H36N6O10 (532.2493)

Lys Glu Trp Ala

C25H36N6O7 (532.2645)

Lys Pro Cys Trp

C25H36N6O5S (532.2468)

Lys Pro Trp Cys

C25H36N6O5S (532.2468)

Lys Gln Glu Glu

C21H36N6O10 (532.2493)

Lys Arg Asp Asp

C20H36N8O9 (532.2605)

Lys Trp Ala Glu

C25H36N6O7 (532.2645)

Lys Trp Cys Pro

C25H36N6O5S (532.2468)

Lys Trp Glu Ala

C25H36N6O7 (532.2645)

Lys Trp Pro Cys

C25H36N6O5S (532.2468)

Leu His Thr Tyr

C25H36N6O7 (532.2645)

Leu His Tyr Thr

C25H36N6O7 (532.2645)

Leu Asn Thr Trp

C25H36N6O7 (532.2645)

Leu Asn Trp Thr

C25H36N6O7 (532.2645)

Leu Gln Ser Trp

C25H36N6O7 (532.2645)

Leu Gln Trp Ser

C25H36N6O7 (532.2645)

Leu Ser Gln Trp

C25H36N6O7 (532.2645)

Leu Ser Trp Gln

C25H36N6O7 (532.2645)

Leu Thr His Tyr

C25H36N6O7 (532.2645)

Leu Thr Asn Trp

C25H36N6O7 (532.2645)

Leu Thr Trp Asn

C25H36N6O7 (532.2645)

Leu Thr Tyr His

C25H36N6O7 (532.2645)

Leu Trp Asn Thr

C25H36N6O7 (532.2645)

Leu Trp Gln Ser

C25H36N6O7 (532.2645)

Leu Trp Ser Gln

C25H36N6O7 (532.2645)

Leu Trp Thr Asn

C25H36N6O7 (532.2645)

Leu Tyr His Thr

C25H36N6O7 (532.2645)

Leu Tyr Thr His

C25H36N6O7 (532.2645)

Met Phe His Val

C25H36N6O5S (532.2468)

Met Phe Val His

C25H36N6O5S (532.2468)

Met His Phe Val

C25H36N6O5S (532.2468)

Met His Val Phe

C25H36N6O5S (532.2468)

Met Val Phe His

C25H36N6O5S (532.2468)

Met Val His Phe

C25H36N6O5S (532.2468)

Asn Ile Thr Trp

C25H36N6O7 (532.2645)

Asn Ile Trp Thr

C25H36N6O7 (532.2645)

Asn Leu Thr Trp

C25H36N6O7 (532.2645)

Asn Leu Trp Thr

C25H36N6O7 (532.2645)

Asn Thr Ile Trp

C25H36N6O7 (532.2645)

Asn Thr Leu Trp

C25H36N6O7 (532.2645)

Asn Thr Trp Ile

C25H36N6O7 (532.2645)

Asn Thr Trp Leu

C25H36N6O7 (532.2645)

Asn Trp Ile Thr

C25H36N6O7 (532.2645)

Asn Trp Leu Thr

C25H36N6O7 (532.2645)

Asn Trp Thr Ile

C25H36N6O7 (532.2645)

Asn Trp Thr Leu

C25H36N6O7 (532.2645)

Pro Cys Lys Trp

C25H36N6O5S (532.2468)

Pro Cys Trp Lys

C25H36N6O5S (532.2468)

Pro Lys Cys Trp

C25H36N6O5S (532.2468)

Pro Lys Trp Cys

C25H36N6O5S (532.2468)

Pro Trp Cys Lys

C25H36N6O5S (532.2468)

Pro Trp Lys Cys

C25H36N6O5S (532.2468)

Gln Glu Glu Lys

C21H36N6O10 (532.2493)

Gln Glu Lys Glu

C21H36N6O10 (532.2493)

Gln Glu Arg Thr

C20H36N8O9 (532.2605)

Gln Glu Thr Arg

C20H36N8O9 (532.2605)

Gln Ile Ser Trp

C25H36N6O7 (532.2645)

Gln Ile Trp Ser

C25H36N6O7 (532.2645)

Gln Lys Glu Glu

C21H36N6O10 (532.2493)

Gln Leu Ser Trp

C25H36N6O7 (532.2645)

Gln Leu Trp Ser

C25H36N6O7 (532.2645)

Gln Arg Glu Thr

C20H36N8O9 (532.2605)

Gln Arg Thr Glu

C20H36N8O9 (532.2605)

Gln Ser Ile Trp

C25H36N6O7 (532.2645)

Gln Ser Leu Trp

C25H36N6O7 (532.2645)

Gln Ser Trp Ile

C25H36N6O7 (532.2645)

Gln Ser Trp Leu

C25H36N6O7 (532.2645)

Gln Thr Glu Arg

C20H36N8O9 (532.2605)

Gln Thr Arg Glu

C20H36N8O9 (532.2605)

Gln Thr Val Trp

C25H36N6O7 (532.2645)

Gln Thr Trp Val

C25H36N6O7 (532.2645)

Gln Val Thr Trp

C25H36N6O7 (532.2645)

Gln Val Trp Thr

C25H36N6O7 (532.2645)

Gln Trp Ile Ser

C25H36N6O7 (532.2645)

Gln Trp Leu Ser

C25H36N6O7 (532.2645)

Gln Trp Ser Ile

C25H36N6O7 (532.2645)

Gln Trp Ser Leu

C25H36N6O7 (532.2645)

Gln Trp Thr Val

C25H36N6O7 (532.2645)

Gln Trp Val Thr

C25H36N6O7 (532.2645)

Arg Asp Asp Lys

C20H36N8O9 (532.2605)

Arg Asp Gly Trp

C23H32N8O7 (532.2394)

Arg Asp Lys Asp

C20H36N8O9 (532.2605)

Arg Asp Arg Ser

C19H36N10O8 (532.2717)

Arg Asp Ser Arg

C19H36N10O8 (532.2717)

Arg Asp Trp Gly

C23H32N8O7 (532.2394)

Arg Glu Gln Thr

C20H36N8O9 (532.2605)

Arg Glu Thr Gln

C20H36N8O9 (532.2605)

Arg Gly Asp Trp

C23H32N8O7 (532.2394)

Arg Lys Asp Asp

C20H36N8O9 (532.2605)

Arg Gln Glu Thr

C20H36N8O9 (532.2605)

Arg Gln Thr Glu

C20H36N8O9 (532.2605)

Arg Arg Asp Ser

C19H36N10O8 (532.2717)

Arg Arg Ser Asp

C19H36N10O8 (532.2717)

Arg Ser Asp Arg

C19H36N10O8 (532.2717)

Arg Ser Arg Asp

C19H36N10O8 (532.2717)

Arg Thr Glu Gln

C20H36N8O9 (532.2605)

Arg Thr Gln Glu

C20H36N8O9 (532.2605)

Ser Asp Arg Arg

C19H36N10O8 (532.2717)

Ser Ile Gln Trp

C25H36N6O7 (532.2645)

Ser Ile Trp Gln

C25H36N6O7 (532.2645)

Ser Leu Gln Trp

C25H36N6O7 (532.2645)

Ser Leu Trp Gln

C25H36N6O7 (532.2645)

Ser Gln Ile Trp

C25H36N6O7 (532.2645)

Ser Gln Leu Trp

C25H36N6O7 (532.2645)

Ser Gln Trp Ile

C25H36N6O7 (532.2645)

Ser Gln Trp Leu

C25H36N6O7 (532.2645)

Ser Arg Asp Arg

C19H36N10O8 (532.2717)

Ser Arg Arg Asp

C19H36N10O8 (532.2717)

Ser Trp Ile Gln

C25H36N6O7 (532.2645)

Ser Trp Leu Gln

C25H36N6O7 (532.2645)

Ser Trp Gln Ile

C25H36N6O7 (532.2645)

Ser Trp Gln Leu

C25H36N6O7 (532.2645)

Thr Glu Gln Arg

C20H36N8O9 (532.2605)

Thr Glu Arg Gln

C20H36N8O9 (532.2605)

Thr His Ile Tyr

C25H36N6O7 (532.2645)

Thr His Leu Tyr

C25H36N6O7 (532.2645)

Thr His Tyr Ile

C25H36N6O7 (532.2645)

Thr His Tyr Leu

C25H36N6O7 (532.2645)

Thr Ile His Tyr

C25H36N6O7 (532.2645)

Thr Ile Asn Trp

C25H36N6O7 (532.2645)

Thr Ile Trp Asn

C25H36N6O7 (532.2645)

Thr Ile Tyr His

C25H36N6O7 (532.2645)

Thr Leu His Tyr

C25H36N6O7 (532.2645)

Thr Leu Asn Trp

C25H36N6O7 (532.2645)

Thr Leu Trp Asn

C25H36N6O7 (532.2645)

Thr Leu Tyr His

C25H36N6O7 (532.2645)

Thr Asn Ile Trp

C25H36N6O7 (532.2645)

Thr Asn Leu Trp

C25H36N6O7 (532.2645)

Thr Asn Trp Ile

C25H36N6O7 (532.2645)

Thr Asn Trp Leu

C25H36N6O7 (532.2645)

Thr Gln Glu Arg

C20H36N8O9 (532.2605)

Thr Gln Arg Glu

C20H36N8O9 (532.2605)

Thr Gln Val Trp

C25H36N6O7 (532.2645)

Thr Gln Trp Val

C25H36N6O7 (532.2645)

Thr Arg Glu Gln

C20H36N8O9 (532.2605)

Thr Val Gln Trp

C25H36N6O7 (532.2645)

Thr Val Trp Gln

C25H36N6O7 (532.2645)

Thr Trp Ile Asn

C25H36N6O7 (532.2645)

Thr Trp Leu Asn

C25H36N6O7 (532.2645)

Thr Trp Asn Ile

C25H36N6O7 (532.2645)

Thr Trp Asn Leu

C25H36N6O7 (532.2645)

Thr Trp Gln Val

C25H36N6O7 (532.2645)

Thr Trp Val Gln

C25H36N6O7 (532.2645)

Thr Tyr His Ile

C25H36N6O7 (532.2645)

Thr Tyr His Leu

C25H36N6O7 (532.2645)

Thr Tyr Ile His

C25H36N6O7 (532.2645)

Thr Tyr Leu His

C25H36N6O7 (532.2645)

Val Phe His Met

C25H36N6O5S (532.2468)

Val Phe Met His

C25H36N6O5S (532.2468)

Val His Phe Met

C25H36N6O5S (532.2468)

Val His Met Phe

C25H36N6O5S (532.2468)

Val Met Phe His

C25H36N6O5S (532.2468)

Val Met His Phe

C25H36N6O5S (532.2468)

Val Gln Thr Trp

C25H36N6O7 (532.2645)

Val Gln Trp Thr

C25H36N6O7 (532.2645)

Val Thr Gln Trp

C25H36N6O7 (532.2645)

Val Thr Trp Gln

C25H36N6O7 (532.2645)

Val Trp Gln Thr

C25H36N6O7 (532.2645)

Val Trp Thr Gln

C25H36N6O7 (532.2645)

Trp Ala Ala Trp

C28H32N6O5 (532.2434)

Trp Ala Glu Lys

C25H36N6O7 (532.2645)

Trp Ala Lys Glu

C25H36N6O7 (532.2645)

Trp Ala Trp Ala

C28H32N6O5 (532.2434)

Trp Cys Lys Pro

C25H36N6O5S (532.2468)

Trp Cys Pro Lys

C25H36N6O5S (532.2468)

Trp Glu Ala Lys

C25H36N6O7 (532.2645)

Trp Glu Lys Ala

C25H36N6O7 (532.2645)

Trp Ile Asn Thr

C25H36N6O7 (532.2645)

Trp Ile Gln Ser

C25H36N6O7 (532.2645)

Trp Ile Ser Gln

C25H36N6O7 (532.2645)

Trp Ile Thr Asn

C25H36N6O7 (532.2645)

Trp Lys Ala Glu

C25H36N6O7 (532.2645)

Trp Lys Cys Pro

C25H36N6O5S (532.2468)

Trp Lys Glu Ala

C25H36N6O7 (532.2645)

Trp Lys Pro Cys

C25H36N6O5S (532.2468)

Trp Leu Asn Thr

C25H36N6O7 (532.2645)

Trp Leu Gln Ser

C25H36N6O7 (532.2645)

Trp Leu Ser Gln

C25H36N6O7 (532.2645)

Trp Leu Thr Asn

C25H36N6O7 (532.2645)

Trp Asn Ile Thr

C25H36N6O7 (532.2645)

Trp Asn Leu Thr

C25H36N6O7 (532.2645)

Trp Asn Thr Ile

C25H36N6O7 (532.2645)

Trp Asn Thr Leu

C25H36N6O7 (532.2645)

Trp Pro Cys Lys

C25H36N6O5S (532.2468)

Trp Pro Lys Cys

C25H36N6O5S (532.2468)

Trp Gln Ile Ser

C25H36N6O7 (532.2645)

Trp Gln Leu Ser

C25H36N6O7 (532.2645)

Trp Gln Ser Ile

C25H36N6O7 (532.2645)

Trp Gln Ser Leu

C25H36N6O7 (532.2645)

Trp Gln Thr Val

C25H36N6O7 (532.2645)

Trp Gln Val Thr

C25H36N6O7 (532.2645)

Trp Arg Asp Gly

C23H32N8O7 (532.2394)

Trp Arg Gly Asp

C23H32N8O7 (532.2394)

Trp Ser Ile Gln

C25H36N6O7 (532.2645)

Trp Ser Leu Gln

C25H36N6O7 (532.2645)

Trp Ser Gln Ile

C25H36N6O7 (532.2645)

Trp Ser Gln Leu

C25H36N6O7 (532.2645)

Trp Thr Ile Asn

C25H36N6O7 (532.2645)

Trp Thr Leu Asn

C25H36N6O7 (532.2645)

Trp Thr Asn Ile

C25H36N6O7 (532.2645)

Trp Thr Asn Leu

C25H36N6O7 (532.2645)

Trp Thr Gln Val

C25H36N6O7 (532.2645)

Trp Thr Val Gln

C25H36N6O7 (532.2645)

Trp Val Gln Thr

C25H36N6O7 (532.2645)

Trp Val Thr Gln

C25H36N6O7 (532.2645)

Trp Trp Ala Ala

C28H32N6O5 (532.2434)

Tyr His Ile Thr

C25H36N6O7 (532.2645)

Tyr His Leu Thr

C25H36N6O7 (532.2645)

Tyr His Thr Ile

C25H36N6O7 (532.2645)

Tyr His Thr Leu

C25H36N6O7 (532.2645)

Tyr Ile His Thr

C25H36N6O7 (532.2645)

Tyr Ile Thr His

C25H36N6O7 (532.2645)

Tyr Leu His Thr

C25H36N6O7 (532.2645)

Tyr Leu Thr His

C25H36N6O7 (532.2645)

Tyr Thr His Ile

C25H36N6O7 (532.2645)

Tyr Thr His Leu

C25H36N6O7 (532.2645)

Tyr Thr Ile His

C25H36N6O7 (532.2645)

Tyr Thr Leu His

C25H36N6O7 (532.2645)

2-Anilino-6-dibutylamino-3-methylfluoran

C35H36N2O3 (532.2726)

dde-lys(fmoc)-oh

C31H36N2O6 (532.2573)

Fmoc-Lys(Dde)-OH

C31H36N2O6 (532.2573)

Nickel, dichlorobis(tributylphosphine)-

C24H54Cl2NiP2 (532.2431)

Fmoc-L-Dap(ivDde)-OH

C31H36N2O6 (532.2573)

Ametantrone acetate

C26H36N4O8 (532.2533)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000970 - Antineoplastic Agents

(2R,6S)-2-amino-6-[[(4R)-4-[[(2S)-2-aminopropanoyl]amino]-4-carboxybutanoyl]amino]-7-[[(2R)-1-[[(1R)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-7-oxoheptanoic acid

C21H36N6O10 (532.2493)

methyl (2S,3R,4S)-3-ethyl-4-[[(1S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]methyl]-2-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylate

C27H36N2O9 (532.2421)

PA(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H41O10P (532.2437)

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0)

C25H41O10P (532.2437)

PA(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H41O10P (532.2437)

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0)

C25H41O10P (532.2437)

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0)

C25H41O10P (532.2437)

Ajuganipponin B

C29H40O9 (532.2672)

A diterpene lactone isolated from the whole plants of Ajuga ciliata.

Glu-Lys-Trp-Ala

C25H36N6O7 (532.2645)

A tetrapeptide composed of L-glutamic acid, L-lysine, L-tryptophan and L-alanine joined in sequence by peptide linkages.

(4-methoxyphenyl) N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(4-methoxyphenyl) N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(4-methoxyphenyl) N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C28H35F3N4O3 (532.2661)

(2S)-2-[(4S,5R)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2R)-2-[(4S,5S)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2S)-2-[(4R,5S)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(4-methoxyphenyl) N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(4-methoxyphenyl) N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(4-methoxyphenyl) N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

(2R)-2-[(4S,5R)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2R)-2-[(4R,5S)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2S)-2-[(4S,5S)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2S)-2-[(4R,5R)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(2R)-2-[(4R,5R)-8-(2-methoxyphenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C28H40N2O6S (532.2607)

(4-methoxyphenyl) N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate

C31H36N2O6 (532.2573)

[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-[oxo(pyridin-4-yl)methyl]-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone

C30H36N4O5 (532.2686)

[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-[oxo(pyridin-4-yl)methyl]-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone

C30H36N4O5 (532.2686)

(1R,3R,8R,12S,13R,17R,20Z,24R,25S,26S)-12-hydroxy-17-[(1R)-1-hydroxyethyl]-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2-oxirane]-11,22-dione

C29H40O9 (532.2672)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C25H41O10P (532.2437)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C25H41O10P (532.2437)

(1R,3R,8R,12S,13R,17R,18E,20Z,24R,25S,26R)-12-hydroxy-17-[(1R)-1-hydroxyethyl]-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2-oxirane]-11,22-dione

C29H40O9 (532.2672)

D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

PA 14:1/8:3;O2

C25H41O10P (532.2437)

PA 18:3/4:1;O2

C25H41O10P (532.2437)

PA 22:4;O2

C25H41O10P (532.2437)

ST 19:0;O6;GlcA

C25H40O12 (532.252)

ST 23:4;O3;GlcA

C29H40O9 (532.2672)

ST 19:1;O7;Hex

C25H40O12 (532.252)

ST 23:5;O4;Hex

C29H40O9 (532.2672)

ST 26:1;O6;S

C26H44O9S (532.2706)

ST 29:6;O4;S

C29H40O7S (532.2495)

(1's,2'r,7'r,9'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7s)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,9'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

5,6,22-trihydroxy-8,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(1s,3ar,5ar,7r,8s,9ar,9br,11ar)-1-[(2r,3r)-2,3-dihydroxy-4-(3-methyl-2-oxo-5,6-dihydropyran-4-yl)butan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,11-dione

C29H40O9 (532.2672)

(1s,3r,5s,7r,9r,10s,12r,14r,18r,19r,22s)-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

11-isopropyl-4,7,14-trimethyl-18-(sec-butyl)-6,13-dioxa-20-thia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),16,19(22)-heptaene-2,9,16-triol

C25H36N6O5S (532.2468)

(4s)-4-[(1e,3s)-3-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}but-1-en-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C25H40O12 (532.252)

(1r,3s,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-8-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl (2z)-2-methylbut-2-enoate

C29H40O9 (532.2672)

3-(3,4-dihydroxyphenyl)-n-[4,7,10-trihydroxy-2,9,13-trimethyl-6-(2-methylpropyl)-14-oxo-1-oxa-5,8,11-triazacyclotetradeca-4,7,10-trien-3-yl]prop-2-enimidic acid

C26H36N4O8 (532.2533)

1,22-dihydroxy-10-(1-hydroxyethyl)-2,14,22-trimethyl-4,11,17,25-tetraoxapentacyclo[21.3.1.1³,²⁶.0²,¹⁹.0¹⁹,²⁴]octacosa-6,8,14-triene-5,16-dione

C29H40O9 (532.2672)

(1'r,2s,3'r,8'r,13'r,14's,17'r,18'e,20'z,24'r,25's)-14'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1r,3r,4r,5r,7s,8r,9r,10z,12s,13s,14s)-4,13-bis(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

(9s,10r)-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl (2e)-3-phenylprop-2-enoate

C32H36O7 (532.2461)

(4R)-4-hydroxy-4-[(E,3S)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one

C25H40O12 (532.252)

{"Ingredient_id": "HBIN010856","Ingredient_name": "(4R)-4-hydroxy-4-[(E,3S)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one","Alias": "(4R)-4-hydroxy-4-[(E,3S)-3-hydroxybut-1-enyl]-3,5,5-trimethyl-1-cyclohex-2-enone; (4R)-4-hydroxy-4-[(E,3S)-3-hydroxybut-1-enyl]-3,5,5-trimethyl-cyclohex-2-en-1-one","Ingredient_formula": "C25H40O12","Ingredient_Smile": "NA","Ingredient_weight": "532.58","OB_score": "30.24475007","CAS_id": "81425-28-7","SymMap_id": "SMIT13678","TCMID_id": "NA","TCMSP_id": "MOL012966","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

4,13-bis(acetyloxy)-8-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl 2-methylbut-2-enoate

C29H40O9 (532.2672)

1-ethenyl-6,13-dihydroxy-15-(7-hydroxy-2,8-dimethyl-9,10-dihydrophenanthren-3-yl)-7,13-dimethyltetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadeca-2(11),3,5,7-tetraen-14-one

C36H36O4 (532.2613)

(1'r,2r,3'r,8'r,12's,13'r,17'r,18'z,20'z,24'r,25's)-12'-hydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1's,2'r,7'r,9'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,9'r,11'r)-2'-({[(2z)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6r,7s)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(3s)-5-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r)-4-[(1s)-2-(hydroxymethyl)-6,6-dimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxy}oxan-4-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C25H40O12 (532.252)

4-[(3r,5s,9s,10s,12r,14r,15r,17s,18s,19r,22s,23r)-10,17,22-trihydroxy-9-methoxy-14,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-19-yl]-5h-furan-2-one

C29H40O9 (532.2672)

(1r,12s,13s,15r)-1-ethenyl-6,13-dihydroxy-15-(7-hydroxy-2,8-dimethyl-9,10-dihydrophenanthren-3-yl)-7,13-dimethyltetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadeca-2(11),3,5,7-tetraen-14-one

C36H36O4 (532.2613)

(1s,3r,7r,10s,13r,15r,16s,17r,18r)-1,15-dihydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]propan-2-yl]-9,9,18-trimethyl-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁶,¹⁸]icosane-5,14-dione

C29H40O9 (532.2672)

(1r,12s,13s,15r)-1-ethenyl-5,13-dihydroxy-15-(7-hydroxy-2,8-dimethyl-9,10-dihydrophenanthren-4-yl)-6,13-dimethyltetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadeca-2(11),3,5,7-tetraen-14-one

C36H36O4 (532.2613)

(1'r,2s,3'r,8'r,12's,13'r,17'r,18'e,20'z,24'r,25's)-12'-hydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1r,2s,3r,4s,6r,7r,8r,9r,12s,13s)-9,12-bis(acetyloxy)-3-(chloromethyl)-3,13-dihydroxy-6-isopropyl-9,13-dimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl acetate

C26H41ClO9 (532.2439)

(1s,3r,5s,7r,9s,10s,12r,14r,15r,18r,19r,22s,23r)-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(4r)-3,5,5-trimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}but-1-en-1-yl]cyclohex-2-en-1-one

C25H40O12 (532.252)

4,13-bis(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl 2-methylbut-2-enoate

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (6s,7s)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

4-{3a,8-dihydroxy-7-[(3-hydroxy-4-methoxyoxan-2-yl)oxy]-9a,11a-dimethyl-11-oxo-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

C29H40O9 (532.2672)

4-(3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}but-1-en-1-yl)-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C25H40O12 (532.252)

(1r,3r,4r,5r,7s,8s,10e,12s,13s,14s)-4,13-bis(acetyloxy)-9-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

5-{[3,5-dihydroxy-2-(hydroxymethyl)-6-({4-[2-(hydroxymethyl)-6,6-dimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl}oxy)oxan-4-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C25H40O12 (532.252)

4,11,18-triisopropyl-7-methyl-6,13-dioxa-20-thia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),16,19(22)-heptaene-2,9,16-triol

C25H36N6O5S (532.2468)

(4s,7r,8s,11s,15s,18s)-4,11,18-triisopropyl-7-methyl-6,13-dioxa-20-thia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),16,19(22)-heptaene-2,9,16-triol

C25H36N6O5S (532.2468)

4-[(1r,3ar,6r,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C29H40O9 (532.2672)

(1s,3r,5s,7r,9r,10s,12r,14r,15r,18r,19r,22s,23r)-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(18'e)-14'-hydroxy-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1'r,2s,3'r,8'r,12's,13'r,17'r,24'r,25's)-12'-hydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,18r,19r,22r)-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(1r,3s,4s,5r,7s,8r,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-8-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,9'r,11'r)-2'-({[(3e)-5-hydroxy-3-methylpent-3-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1'r,2s,3'r,8'r,12's,13'r,17'r,18'e,20'z,24'r,25's)-12'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1'r,2r,3'r,8'r,12's,13'r,17's,18'e,20'z,24'r,25's)-12'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1s,3r,7r,9r,10s,13s,14r,15s,17r)-1,15-dihydroxy-17-[(1s,2s)-1-hydroxy-1-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]propan-2-yl]-9-(hydroxymethyl)-9,14-dimethyl-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-18-en-5-one

C29H40O9 (532.2672)

(18'e,20'z)-14'-hydroxy-17'-(1-hydroxyethyl)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl 3-phenylprop-2-enoate

C32H36O7 (532.2461)

(1s,2s,5r,6r)-5,6-bis(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)-2-(piperidine-1-carbonyl)cyclohex-3-ene-1-carboximidic acid

C31H36N2O6 (532.2573)

(2s)-2-amino-n-[(2s)-1-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoyl]oxy}-3-(1h-indol-3-yl)-1-oxopropan-2-yl]propanimidic acid

C28H32N6O5 (532.2434)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-8-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

9-[6-(acetyloxy)hex-4-en-1-yl]-5-octyl-1,3-dioxo-4h,5h,8h,9h,10h-cyclonona[c]furan-6,7-dicarboxylic acid

C29H40O9 (532.2672)

1-ethenyl-5,13-dihydroxy-15-(7-hydroxy-2,8-dimethyl-9,10-dihydrophenanthren-4-yl)-6,13-dimethyltetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadeca-2(11),3,5,7-tetraen-14-one

C36H36O4 (532.2613)

(2r,12's,13'r,17'r,18'z,20'e,24's,25's)-12'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

2'-{[(5-hydroxy-3-methylpent-3-enoyl)oxy]methyl}-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl 6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1'r,2s,3'r,8'r,12'r,13's,17'r,18'e,20'z,24'r,25's)-12'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1r,2s,5r,6s)-2,6-bis(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)-5-(piperidine-1-carbonyl)cyclohex-3-ene-1-carboximidic acid

C31H36N2O6 (532.2573)

(1'r,2s,3'r,8'r,12's,13'r,17's,18'e,20'z,24'r,25's)-12'-hydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

2,6-bis(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)-5-(piperidine-1-carbonyl)cyclohex-3-ene-1-carboximidic acid

C31H36N2O6 (532.2573)

(4s)-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}but-1-en-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C25H40O12 (532.252)

(1s,2s,8s,17s,19r)-12-hydroxy-19-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaene-14,18-dione

C32H36O7 (532.2461)

2'-{[(5-hydroxy-3-methylpent-2-enoyl)oxy]methyl}-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl 6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(20r,24s,26s)-7-ethenyl-12-ethyl-19,20-dihydroxy-6,11,26,27-tetramethyl-2,16,28,29-tetraazaheptacyclo[15.7.1.1³,²⁴.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²⁰,²⁵]nonacosa-1(25),3,5(29),6,8,10(28),11,13,15(27),16,18-undecaen-21-one

C33H32N4O3 (532.2474)

(1s,3r,7r,9r,10s,13s,14r,15s,17r)-1,15-dihydroxy-17-[(1s,2s)-1-hydroxy-1-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propan-2-yl]-9-(hydroxymethyl)-9,14-dimethyl-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-18-en-5-one

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,9'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7s)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

(1's,2s,2'r,7'r,9'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2e,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

1-[2,3-dihydroxy-4-(3-methyl-2-oxo-5,6-dihydropyran-4-yl)butan-2-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthrene-5,11-dione

C29H40O9 (532.2672)

9,10,22-trihydroxy-19-(5-hydroxy-2,5-dihydrofuran-3-yl)-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-23-ene-14-carbaldehyde

C29H40O9 (532.2672)

(2s,3r,4r,7'r)-4-(3-ethyl-4-methoxy-3-methyl-2,4-dioxobutyl)-11'-hydroxy-3-methyl-7'-pentyl-2',6'-dioxaspiro[oxolane-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),9',11'-triene-12'-carboxylic acid

C29H40O9 (532.2672)

(4s)-4-[(1s,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxypentanoic acid

C29H40O9 (532.2672)

(1'r,3'r,8'r,12's,13'r,17'r,18'z,20'z,24'r,25's)-12'-hydroxy-17'-[(1r)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

(1'r,2s,3'r,8'r,12's,13'r,17'r,24'r,25's)-12'-hydroxy-17'-[(1s)-1-hydroxyethyl]-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',22'-dione

C29H40O9 (532.2672)

1,15-dihydroxy-17-[1-hydroxy-1-(4-methyl-5-oxo-2h-furan-2-yl)propan-2-yl]-9-(hydroxymethyl)-9,14-dimethyl-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁴,¹⁸]icos-18-en-5-one

C29H40O9 (532.2672)

12-hydroxy-19-(4-hydroxy-3-methylbut-2-en-1-yl)-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaene-14,18-dione

C32H36O7 (532.2461)

(1's,2s,2'r,7'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (6s,7r)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)

4-[(1s,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxypentanoic acid

C29H40O9 (532.2672)

2-{4-hydroxy-1,4a-dimethyl-2,5-dimethylidene-8-[(2-methylpropanoyl)oxy]-3-oxo-tetrahydro-4h-naphthalen-1-yl}-1-(3-hydroxy-5-oxooxolan-3-yl)ethyl 2-methylbut-2-enoate

C29H40O9 (532.2672)

(1s,3r,5s,6r,8r,10s,12r,14r,15s,18r,19r,22s,23r)-5,6,22-trihydroxy-8,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(1r)-2-[(1s,4s,4as,8s,8as)-4-hydroxy-1,4a-dimethyl-2,5-dimethylidene-8-[(2-methylpropanoyl)oxy]-3-oxo-tetrahydro-4h-naphthalen-1-yl]-1-[(3s)-3-hydroxy-5-oxooxolan-3-yl]ethyl (2e)-2-methylbut-2-enoate

C29H40O9 (532.2672)

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,22r,23r)-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O9 (532.2672)

(2e)-3-(3,4-dihydroxyphenyl)-n-[(2r,3s,6s,9r,13s)-4,7,10-trihydroxy-2,9,13-trimethyl-6-(2-methylpropyl)-14-oxo-1-oxa-5,8,11-triazacyclotetradeca-4,7,10-trien-3-yl]prop-2-enimidic acid

C26H36N4O8 (532.2533)

1,15-dihydroxy-17-[1-hydroxy-1-(4-methyl-5-oxo-2h-furan-2-yl)propan-2-yl]-9,9,18-trimethyl-4,8-dioxapentacyclo[11.7.0.0³,⁷.0³,¹⁰.0¹⁶,¹⁸]icosane-5,14-dione

C29H40O9 (532.2672)

4-[11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxypentanoic acid

C29H40O9 (532.2672)

(1r,2s,3r,6z,8e,10r,14e,19r,22s,23s,24r,26r)-1,22-dihydroxy-10-[(1r)-1-hydroxyethyl]-2,14,22-trimethyl-4,11,17,25-tetraoxapentacyclo[21.3.1.1³,²⁶.0²,¹⁹.0¹⁹,²⁴]octacosa-6,8,14-triene-5,16-dione

C29H40O9 (532.2672)

4-{10,17,22-trihydroxy-9-methoxy-14,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-19-yl}-5h-furan-2-one

C29H40O9 (532.2672)

(5r,9s)-9-[(4e)-6-(acetyloxy)hex-4-en-1-yl]-5-octyl-1,3-dioxo-4h,5h,8h,9h,10h-cyclonona[c]furan-6,7-dicarboxylic acid

C29H40O9 (532.2672)

5,6-bis(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)-2-(piperidine-1-carbonyl)cyclohex-3-ene-1-carboximidic acid

C31H36N2O6 (532.2573)

(1s,3r,5s,7s,9r,10s,12r,14r,15s,18r,19r,22r)-9,10,22-trihydroxy-19-[(5r)-5-hydroxy-2,5-dihydrofuran-3-yl]-7,18-dimethyl-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-23-ene-14-carbaldehyde

C29H40O9 (532.2672)

(4r,7r,8s,11s,14r,15s,18r)-18-[(2s)-butan-2-yl]-11-isopropyl-4,7,14-trimethyl-6,13-dioxa-20-thia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),9,12(23),16,19(22)-heptaene-2,9,16-triol

C25H36N6O5S (532.2468)

(1's,2s,2'r,7'r,11'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z,4e,6s,7s)-6,7-dihydroxyocta-2,4-dienoate

C29H40O9 (532.2672)